Notable Upward Momentum: Longeveron (LGVN) Stock Soars On Clinical Trial Progress
Longeveron Inc. (NASDAQ: LGVN) shares witnessed a significant surge of 20.48% in the preceding trading session, culminating at $3.53 per share. This notable increase in LGVN’s stock value can be attributed to recent advancements in a clinical trial endeavor. In order to highlight the findings of the company’s CLEAR MIND Phase 2a trial, Longeveron (LGVN) […]